The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694
1988

Anti-emetic Potential of BRL 43694

Sample size: 8 publication Evidence: high

Author Information

Author(s): J. Bermudez, E.A. Boyle, W.D. Miner, G.J. Sanger

Primary Institution: Beecham Pharmaceuticals Research Division

Hypothesis

Can BRL 43694 effectively reduce vomiting induced by chemotherapy and radiation in ferrets?

Conclusion

BRL 43694 is a highly effective anti-emetic that can prevent vomiting caused by various emetic stimuli in ferrets.

Supporting Evidence

  • BRL 43694 significantly reduced vomiting in ferrets exposed to cisplatin.
  • BRL 43694 abolished vomiting within 30 seconds when given during an emetic episode.
  • BRL 43694 prevented emesis caused by cyclophosphamide and doxorubicin.
  • BRL 43694 also prevented vomiting induced by X-irradiation.

Takeaway

BRL 43694 is a medicine that helps stop animals from throwing up when they get sick from treatments like chemotherapy.

Methodology

The study involved administering BRL 43694 to ferrets before and after exposure to emetic stimuli and observing the effects on vomiting.

Limitations

The study was conducted on ferrets, and results may not directly translate to humans.

Participant Demographics

Male polecat or albino ferrets, 1-2 kg.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication